Main Menu

Clinical Pharmacology Adaptive Therapy Group

Professor Banerji's team aims to study re-wiring of signal transduction to understand and overcome mechanisms of drug resistance and, in addition, to understand exploit cancer evolution using pharmacological tools.

Team leader

Professor Udai Banerji

Professor Udai Banerji

Professor Udai Banerji champions multidisciplinary working at the interface between early phase clinical trials, drug discovery and translational research related to drug resistance. He is Deputy Director of the Drug Development Unit at The ICR and Royal Marsden, and as a key member of the Cancer Research UK Cancer Therapeutics Unit, also heads the Clinical Pharmacodynamics Biomarker Group and the Clinical Pharmacology-Adaptive Therapy Group.

ORCID 0000-0003-1503-3123

Team members

Dr Alexandros Georgiou

Clinical Research Fellow

Dr Lisa Pickard

Higher Scientific Officer

Adam Stewart

Higher Scientific Officer

Parames Thavasu

Scientific Officer